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stricter HEC deﬁnition of thrust, and (2) restricting analyses to persons
with deﬁnite knee OA yielded similar results.
OR adjusted for all other factors in table
For VARUS thrust
(95%CI)
For VALGUS thrust
(95%CI)
African-American 0.74 (0.55, 0.98) 2.34 (1.56, 3.51)
Age (OR per 1 year) 1.03 (1.02, 1.04) 1.01 (0.99, 1.03)
Female 0.70 (0.57, 0.86) 0.77 (0.52, 1.14)
BMI (OR per 1 unit) 1.03 (1.01, 1.05) 0.98 (0.95, 1.02)
Knee injury 1.07 (0.89, 1.27) 0.82 (0.57, 1.18)
Knee surgery 1.03 (0.82, 1.31) 1.27 (0.82, 1.96)
K/L grade 1 1.25 (0.99, 1.57) 0.94 (0.60, 1.47)
K/L grade 2 0.89 (0.68, 1.18) 1.15 (0.71, 1.87)
K/L grade 3 1.59 (1.23, 2.05) 1.28 (0.79, 2.08)
K/L grade 4 2.17 (1.56, 3.03) 2.48 (1.44, 4.29)
Varus malalignment (OR per 1 degree) 1.05 (1.03, 1.07) −-
Valgus malalignment (OR per 1 degree) −- 1.10 (1.05, 1.16)
Knee extensor strength (OR per 20 units) 0.98 (0.98, 0.99) 1.00 (0.98, 1.01)
Conclusions: In sum, risk factors for prevalent varus thrust included C
race, male gender, and greater age, BMI, disease severity, and varus
malalignment. Risk factors for prevalent valgus thrust included AA race,
disease severity, and greater valgus malalignment. Varus thrust was
more common than valgus thrust. AA were at greater risk for hav-
ing a valgus thrust, in keeping with prior ﬁndings suggesting lateral
tibiofemoral OA may be more common in AA (Jordan et al, Arthritis
Rheum 2006;54:S307).
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Purpose: Osteoarthritis (OA) is the most frequent type of arthritis, and
yet the requirements for patients with OA are rarely considered from a
health care system perspective. As part of the development of models to
care for OA, the purpose of this study is to document the amount and
type of care delivered for OA, including use of surgery.
Methods: The setting was a jurisdiction (population approx 12 million).
Analysis of all physician billings from health service administrative data
bases for all settings (primary care, emergency room, day surgery and
inpatient) by diagnostic code, physician type, and geographic area, for
years 2006−07. In addition all patients with OA seeing an orthopedic
surgeon in 2005, and who had not already had surgery in the previous
6 months, were followed for 18 months to monitor surgical events.
Results: 4.3% (approx 0.5 million people) of the population had a least 1
ambulatory visit with a diagnostic code of OA (1.1% for age 15−44; 6.8%
for age 45−64; 15.6% for age 65+). The mean number of visits was 1.9,
and the female:male ratio was 1.6:1. Ambulatory visits for OA represented
21% of all physician visits for musculoskeletal disorders and 5% of visits
to all physicians for all conditions. OA accounted for 38% of inpatient
hospitalizations and 8.6% of day surgeries, but <1% of emergency room
visits.
79% of ambulatory visits were to primary care physicians, and 30% to
specialists (10% saw both). Of specialist visits, 16% were to medical
specialists (5% to rheumatologists and 4% to general internists) and
21% to surgical specialists (almost all to orthopedics). Of those seeing a
surgeon (and with no surgery in previous 6 months) only 29% got surgery
within 18 months of the index visit: i.e. only an estimated 6% of people
with OA ambulatory visits to physicians received a surgical intervention.
Analysis by geographic area for those seeing specialists showed a trade
off between seeing medical and surgical specialists: in areas where a
higher proportion saw medical specialists there was a lesser proportion
who saw surgical specialists. This is likely inﬂuenced by availability of the
different types of practitioners.
Conclusions: Assuming an estimated prevalence of OA of >10%, less
than half have a physician visit each year, mostly to primary care, and a
very small minority have surgery. In view of the documented deﬁciencies
in the primary care management of arthritis, models of care for OA are
needed to ensure timely referral for the minority potentially needing joint
replacement or pain management, and to provide ongoing conservative
management including appropriate use of exercise and self management
for the majority.
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Purpose: Our objective was to estimate the prevalence of physician-
diagnosed osteoarthritis (OA) in Canada. Reliable estimates of OA
prevalence in the general population are needed for surveillance and
assessment of resource utilization.
Methods: We used the Population Health Model (POHEM), a microsim-
ulation model of health, disease and mortality developed by Statistics
Canada, to generate prevalence of OA consistent with OA incidence data.
OA incidence was projected sufﬁciently far into the future to obtain stable
estimates of age-standardized prevalence rates in the general population.
The incidence rates used were estimated from administrative data on all
visits to health professionals and hospital admissions covered by the Med-
ical Services Plan (MSP) of British Columbia, Canada (BC) for the ﬁscal
years 1991/2 through 2000/1. They were estimated by age and sex for a
one-year period between April 1, 2000 and March 31, 2001 and excluded
prevalent cases from the previous 9 years.OA diagnosis was deﬁned as
either 2 visits to a health professional or the ﬁrst hospital separation with
a 3-digit ICD-9 code 715. We assumed the age-sex-speciﬁc rates would
be representative at the national level. Point prevalence rates by age
and sex were also estimated directly from administrative data from all
OA cases over the 10 year period still alive as of March 31, 2001. We
used the cross-sectional Canadian Community Health Survey (2000−01),
representing the household population, to estimate physician-diagnosed
OA from self-reported data.
Results: The overall prevalence rates of OA generated from the simula-
tion for the 2001 population aged 20 and older were 10.5% and 17.3% in
males and females, respectively. The overall prevalence rates directly
estimated from administrative data were 4.8% in males and 6.9% in
females. Self-reported prevalence of OA from survey data for persons
aged 20 and older was 5.8% in males and 12.3% in females for all age
groups combined. The rates were higher for females than males in all
age groups, except under age 45 in administrative data. After age 50,
rates increased approximately linearly with age, except in the survey data
where rates leveled off at age 75. By age 70−74, about one-third of men
and half of women had OA in the POHEM generated data. This was
considerably lower in administrative data (about 20% of men and 25%
of women had been diagnosed with OA) and self-reported survey data
(16% of men and one-third of women reported OA).
Conclusions: The POHEM microsimulation yielded estimates for preva-
lence of OA which were higher than those from physician visit adminis-
trative and self report data, and point to the large impact of this disease
in the population. This method has the advantage of overcoming some of
the limitations of relying solely on administrative data (insufﬁcient years
of data) or on self-report (such as recall bias, lack of saliency, and
ﬂuctuating disease symptoms). This method also offers the possibility
to study the impact of factors affecting incidence (e.g. increasing obesity)
for population surveillance and assessment of potential future resource
utilization.
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Purpose: To construct and describe energy expenditure and hip/knee
joint force measures, and the ratio between them, in different strata of
the population.
Methods: Design: Retrospective cohort. Setting: Canada-wide popula-
tion study.
Participants and Data Collection: Data source: baseline data from the
Physical Activity and Joint Health cohort, a population 3-cycle Internet
